May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
INHIBITION OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION WITH TRANSPUPILLARY THERMOTHERAPY
Author Affiliations & Notes
  • Y. Ming
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Karolinska Institutet, Stockholm, Sweden
    Dept. of Ophthalmology, Second Hospital, Jilin University, Changchun, China
  • P. Algvere
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Karolinska Institutet, Stockholm, Sweden
  • A. Odergren
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Karolinska Institutet, Stockholm, Sweden
  • I. van der Ploeg
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Karolinska Institutet, Stockholm, Sweden
  • S. Seregard
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Karolinska Institutet, Stockholm, Sweden
  • A. Kvanta
    St. Erik's Eye Hospital, Dept. of Clin. Sciences,
    Dept. of Physiology and Pharmacology,
    Karolinska Institutet, Stockholm, Sweden
  • Footnotes
    Commercial Relationships  Y. Ming, None; P. Algvere, None; A. Odergren, None; I. van der Ploeg, None; S. Seregard, None; A. Kvanta, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5133. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Ming, P. Algvere, A. Odergren, I. van der Ploeg, S. Seregard, A. Kvanta; INHIBITION OF EXPERIMENTAL CHOROIDAL NEOVASCULARIZATION WITH TRANSPUPILLARY THERMOTHERAPY . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5133.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose. To evaluate the histological and ultrastructural findings after transpupillary thermotherapy (TTT) of experimental choroidal neovascularization (CNV) using visible and non–visible thermal burns. Methods. CNV was induced in 37 pigmented C57BL/6 mice using a krypton laser where after TTT (power 50, 60 or 80 mW, spot size 1.2 mm, duration 60 s) was delivered to the CNV lesions using a diode laser (emission wavelength 810 nm) and a slit lamp delivery system with a handheld contact lens. Eyes were enucleated 13 days after CNV induction andhematoxylin–eosin stained paraffin embedded sections prepared. Five to 10 serial sections from each CNV complex were measured and the highest value was stored. Ultrastructural changes in the TTT treated CNV lesions were analyzed by transmission electron microscopy. Results. TTT treatment with a power of 50 mW gave no visible effect on the retina whereas treatment with a power of 80 mW resulted in retinal whitening. When TTT was applied over the laser–induced CNV lesions the height of lesions was significantly reduced (p < 0.001) using all three power settings (50 mW, 60 mW and 80 mW). The overlying neural retina showed no apparent damage with the 50 mW or 60 mW settings whereas complete disruption of the outer nuclear layer was seen with a power of 80 mW. Ultrastructural studies confirmed that vascular occlusion was present at 24 h after TTT and that a fibrotic scar was later formed. Conclusions. The results show that TTT can effectively occlude newly formed vessels and decrease the experimental CNV complex without damaging the neural retina.

Keywords: age–related macular degeneration • choroid: neovascularization • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×